APRIL suppression sustained through 12 weeks, supporting Q12W dosing interval ~70% reduction in Gd-IgA1 at 12 weeks ~33-day half-life. NAVIGATE-2 Phase 2 trial enrolling ...
Charles Leclerc set the fastest time at the end of FP1 for the 2026 United States Grand Prix in Austin as Max Verstappen was ...
Climb Bio, Inc. (Nasdaq: CLYM, “Climb Bio”) and Beijing Mabworks Biotech Co., Ltd. (“Mabworks”), today announced additional Phase 1 data in healthy volunteers for CLYM116/MIL116, an anti-APRIL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results